PRN: Global Anticoagulant Market (2017-2021) - Growth Due to Rising Prevalence of Coagulation Disorders - Research and Markets

21/mar/2017 18:30:17 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Global Anticoagulant Market (2017-2021) - Growth Due to Rising Prevalence of Coagulation Disorders - Research and Markets


DUBLIN, Mar. 21, 2017 /PRNewswire/ --

Dublin - Research and Markets has announced the addition of the "Global Anticoagulant Market 2017-2021" report to their offering.

Research and Markets Logo

The  global anticoagulant market to grow at a CAGR of 7.42% during the period 2017-2021.

The report, Global Anticoagulant Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendors operating in this market.

One trend in the market is the strategic alliance. Mergers and acquisitions (M&A) lead the industry toward further consolidation, which, in turn, improves the penetration of the related products. Considering such alliances lead to broader geographical footprint and wider customer base, the underlying market witnesses the benefits regarding volume growth.

According to the report, one driver in the market is the increasing demand for NOACs. The increasing adoption rates of NOACs is driving the market growth. NOACs target either thrombin or factor Xa to prevent and treat thrombosis. They show quick action and do not require continuous monitoring. They also have better safety and efficacy profiles when compared with conventional therapies such as warfarin. Hence, the adoption rate of NOACs has seen an increment in the anticoagulation market. It was observed that 62% of all the anticoagulant prescriptions were for novel oral anticoagulant during 2010-2013.

Key vendors

  • Bayer HealthCare
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Daiichi Sankyo
  • Johnson & Johnson
  • Sanofi

Other prominent vendors

  • Abbott Vascular
  • Abiomed
  • AtriCure
  • Biosensors International
  • Biotronik
  • BioVentrix
  • C. R. Bard

Key Topics Covered:

PART 01: Executive summary

PART 02: Scope of the report

PART 03: Market research methodology

PART 04: Introduction

PART 05: Disease overview

PART 06: Pipeline analysis

PART 07: Market landscape

PART 08: Market segmentation by ROA

PART 09: Market segmentation by drug class

PART 10: Market segmentation by application

PART 11: Geographical segmentation

PART 12: Market drivers

PART 13: Impact of drivers

PART 14: Market challenges

PART 15: Impact of drivers and challenges

PART 16: Market trends

PART 17: Vendor landscape

PART 18: Key vendor analysis

PART 19: Appendix

For more information about this report visit! z/global

Media Contact:

Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716


blog comments powered by Disqus è un servizio offerto da Factotum Srl